New studies create better understanding of cancer-spreading enzymes

December 2, 2015, University of Missouri-Columbia

As a part of the human immune system, white blood cells create a number of enzymes that help fight disease. Sometimes, these enzymes can malfunction, causing damage to the body or increasing cancer growth. Now, researchers at the University of Missouri have determined a detailed structural view of one of these enzymes, called MMP7, as it binds to the membranes, or surfaces, of cancer cells. Steve Van Doren, a professor in the MU Department of Biochemistry, says understanding the structure of this enzyme and how it works with partners will help create future treatments for cancer.

"MMP7 is known to make cancer cells more aggressive and likely to spread throughout the body," Van Doren said. "We now understand that MMP7 signals to cancer cells to become more aggressive when the cuts off specific proteins as it binds to those cancer cells. Knowing this, we hopefully can find ways to prevent these enzymes from binding and signaling to these cancer cells in the first place. The end result could be a way to prevent cancer cells from spreading so rapidly."

For the study, Van Doren and his research team, including lead author Stephen Prior, a postdoctoral fellow at MU, used a highly sophisticated piece of equipment called a Nuclear Magnetic Resonance (NMR) spectrometer to map the structure of assemblies containing MMP7. Functioning similarly to a imaging (MRI) machine, the NMR spectrometer uses large magnets to allow scientists detect the nuclei of atoms in order to reconstruct detailed images of sub-microscopic enzymes. The researchers then study these 3D images to determine how these enzymes work within the body.

Additionally, Van Doren and his research team published a study investigating a sister enzyme, known as MMP14. In this study, Van Doren used the same NMR spectrometer to determine how MMP14 helps cancer spread throughout the body. He says this knowledge also will inform future research into ways to prevent the spread of cancer.

"MMP14 is the most important protein-cutting enzyme in terms of how migrate throughout the body," Van Doren said. "These enzymes essentially cut paths through the collagen meshwork of tissues in the body. By clearing paths through this collagen, the MMP14 enzyme enables tumor cells to move and spread. By understanding the structures of how these enzymes attack collagen and other proteins, we can find ways to block them from allowing cancer to spread."

These studies were published in Structure.

Explore further: Scientists discover new information about how enzymes from white blood cells function

More information: Stephen H. Prior et al. Charge-Triggered Membrane Insertion of Matrix Metalloproteinase-7, Supporter of Innate Immunity and Tumors, Structure (2015). DOI: 10.1016/j.str.2015.08.013

Related Stories

Scientists discover new information about how enzymes from white blood cells function

January 5, 2015
As a part of the human immune system, white blood cells create a number of enzymes that help fight disease. Sometimes, these enzymes damage tissues in inflammatory diseases such as chronic obstructive pulmonary disease, cancer ...

Researchers discover protein that could help prevent the spread of cancer

May 4, 2011
A protein capable of halting the spread of breast cancer cells could lead to a therapy for preventing or limiting the spread of the disease.

Innate immunity may help limit cancer growth

September 17, 2015
Cancer immunotherapy, a relatively new frontier in cancer treatment, works by enhancing the capacity of one's immune system to attack cancer cells. To date, this field has focused on developing cancer vaccines or engineering ...

Researchers develop antibody to save cancerous bones

December 2, 2015
Bone Cancer Primary bone cancer called Osteosarcoma (OS) is a rare cancer most often affecting adolescents and children. While most bone cancers have their origin in other body tissues and spread to the bones through metastases, ...

New paper offers insights into how cancer cells avoid cell death

June 19, 2013
(Medical Xpress)—A new study by a team of researchers from the University of Notre Dame provides an important new insight into how cancer cells are able to avoid the cell death process. The findings may reveal a novel chemotherapeutic ...

Scientists reveal structure of key cancer target enzyme

November 18, 2015
A team from the University of York has published research unveiling the 3-D structure of human heparanase, a sugar-degrading enzyme which has received significant attention as a key target in anti-cancer treatments.

Recommended for you

Pushing closer to a new cancer-fighting strategy

December 11, 2018
A molecular pathway that's frequently mutated in many different forms of cancer becomes active when cells push parts of their membranes outward into bulging protrusions, Johns Hopkins researchers report in a new study. The ...

Scientists have identified and modelled a distinct biology for paediatric AML

December 11, 2018
Scientists have identified and modelled a distinct biology for paediatric acute myeloid leukaemia, one of the major causes of death in children.

HER2 mutations can cause treatment resistance in metastatic ER-positive breast cancer

December 11, 2018
Metastatic breast cancers treated with hormone therapy can become treatment-resistant when they acquire mutations in the human epidermal growth factor receptor 2 (HER2) that were not present in the original tumor, reports ...

Loss of two genes drives a deadly form of colorectal cancer, reveals a potential treatment

December 11, 2018
Colorectal cancers arise from earlier growths, called polyps, found on the inner surface of the colon. Scientists are now learning that polyps use two distinct molecular pathways as they progress to cancer, called the "conventional" ...

Taking uncertainty out of cancer prognosis

December 11, 2018
A cancer diagnosis tells you that you have cancer, but how that cancer will progress is a terrifying uncertainty for most patients. Researchers at Cold Spring Harbor Laboratory (CSHL) have now identified a specific class ...

Successful anti-PD-1 therapy requires interaction between CD8+ T cells and dendritic cells

December 11, 2018
A team led by a Massachusetts General Hospital (MGH) investigator has found that successful cancer immunotherapy targeting the PD-1 molecule requires interaction between cytotoxic CD8+ T cells, which have been considered ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.